Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,599.96
(
0.26%
)
US TECH 100
29,592.40
(
0.20%
)
Dow Jones
51,078.88
(
0.09%
)
Brent Oil
93.57
(
-2.50%
)
Bitcoin
70,874.03
(
-0.69%
)
News Focus
News Focus

Replies to post #853 on Fate Therapeutics Inc (FATE)

Replies to #853 on Fate Therapeutics Inc (FATE)
icon url

NY1972

11/12/25 12:44 PM

#854 RE: jondoeuk #853

Only 1 based on stem cells. Only 1 treating CY refractory SLE patients. looks like 1000 mg CY + 360M 819 will result in Doris remission in 6 months for pts not refractory to CY. 900M will be needed for CY refractory pts.
icon url

NY1972

11/14/25 2:59 PM

#855 RE: jondoeuk #853

The mica A/B NK trial probably did not find any safety issues. 1 day hospital stay and 300M 836 + cetuximab for 1st patient seems bold.